UNDERWRITING AGREEMENTUnderwriting Agreement • February 4th, 2015 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations • New York
Tonix Pharmaceuticals Holding Corp., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC and Oppenheimer & Co. Inc. are acting as representatives (the “Representatives”), an aggregate of 4,900,000 shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company. The Company has granted the Underwriters the option to purchase an aggregate of up to 735,000 shares (the “Option Shares”) of Common Stock as may be necessary to cover over-allotments made in connection with the offering. The Firm Shares and the Option Shares are collectively referred to as the “Securities”.
